Consistent with previous reports that determined elevated NF‐κB activity in ccRCC [69], we confirmed significantly upregulated expression of three members of the NF‐κB transcription factor family (NF‐κB2, RelA, and RelB) in our ccRCC cohort (Fig. S4A). Here, RELB is linked to nonpapillary renal cell carcinoma.